232 related articles for article (PubMed ID: 14963791)
21. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
22. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Chang KH; McAnena OJ
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):253; author reply 253-4. PubMed ID: 19154939
[No Abstract] [Full Text] [Related]
23. [Validity of thoraocscopic radical esophagectomy for cancer].
Osugi H; Takemura M; Lee S
Nihon Geka Gakkai Zasshi; 2005 May; 106(5):352-6. PubMed ID: 15934554
[No Abstract] [Full Text] [Related]
24. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
25. Differences in esophageal cancer treatments.
Skinner DB
World J Surg; 1996 May; 20(4):514. PubMed ID: 8669155
[No Abstract] [Full Text] [Related]
26. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
[TBL] [Abstract][Full Text] [Related]
27. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
28. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
[TBL] [Abstract][Full Text] [Related]
29. New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.
DeMeester SR
Ann Thorac Surg; 2008 Feb; 85(2):S747-50. PubMed ID: 18222209
[No Abstract] [Full Text] [Related]
30. Early-stage adenocarcinoma in Barrett's esophagus: aspects of surgical therapies.
Horváth OP; Kalmár K
Dig Dis; 2009; 27(1):45-53. PubMed ID: 19439960
[TBL] [Abstract][Full Text] [Related]
31. [Lymphadenectomy in surgery for cancers of the stomach and esophagus].
Mariette C; Piessen G; Vons C
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S21-12S29. PubMed ID: 19194354
[TBL] [Abstract][Full Text] [Related]
32. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
33. Three-field lymphadenectomy for esophageal cancer.
Altorki NK
Chest Surg Clin N Am; 2000 Aug; 10(3):553-60. PubMed ID: 10967756
[TBL] [Abstract][Full Text] [Related]
34. Surgery for early stage esophageal adenocarcinoma.
Stein HJ; von Rahden BH; Feith M
J Surg Oncol; 2005 Dec; 92(3):210-7. PubMed ID: 16299789
[TBL] [Abstract][Full Text] [Related]
35. The role of lymphadenectomy in esophageal cancer.
Darling G
J Surg Oncol; 2009 Mar; 99(4):189-93. PubMed ID: 19101951
[TBL] [Abstract][Full Text] [Related]
36. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
37. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
38. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management.
Benzoni E; Terrosu G; Bresadola V; Uzzau A; Intini S; Noce L; Cedolini C; Bresadola F; De Anna D
J Gastrointestin Liver Dis; 2007 Dec; 16(4):395-401. PubMed ID: 18193121
[TBL] [Abstract][Full Text] [Related]
40. Extended surgery for cancer of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
J Surg Res; 2004 Mar; 117(1):58-63. PubMed ID: 15013715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
